You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced or Metastatic NSCL Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

Recruiting
  • Cancer
  • +11 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

Not yet recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • SPH4336 Tablets
  • SPH4336 Tablets Placebo
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

NSCLC Trial in Guangzhou (BL-M07D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 1, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

Recruiting
  • Protein Kinase Inhibitors
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 9, 2023

Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )

Not yet recruiting
  • Quality of Life
  • +2 more
  • ARACOMPLEX®
  • placebo
  • (no location specified)
Nov 28, 2022

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023

Colorectal Cancer Trial (Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute
Jan 3, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Utidelone Injection
  • Docetaxel Injection
  • (no location specified)
Dec 30, 2022

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

Recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 28, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Advanced Cancer Trial in South Brisbane, Bedford Park, Melbourne (AWT020)

Recruiting
  • Advanced Cancer
  • AWT020
  • South Brisbane, Queensland, Australia
  • +2 more
Oct 18, 2023